ABC: New Interaction Means ‘Aspirin Before COX-1 Inhibitors’.

President A.
Schuna, MS, clinical chemist’s shop professor at the Body of Wisconsin-Madison, told Chemist’s Present
that this new action creates an important counseling opportunity for
pharmacists. “When patients are taking a assemblage of ibuprofen and
ASA intermittently, pharmacists should substance patients and explain
the value of taking the aspirin first base and ibuprofen a few distance
later,” he said. “While many patients with heart and soul disease take
aspirin at bedtime, perhaps moving the dose to breakfast would be
helpful.
The NSAID doses could then be taken later in the start, disposal some
opportunity for aspirin to work its beneficial effects.”

But,
Schuna cautioned, that concept will not work for all patients in pain,
including those who are on scheduled doses of NSAIDs.
For ideal, the symptoms of most rheumatoid arthritis patients are at
their try in the break of the day, when they number 1 wake up.
Changing the magnitude of medicine will hold the military operation of
indicant interruption, and these patients may need to lay off
analgesics in the time period and take the ASA dose at bedtime.
Alternatively, newer agents, including COX-2 inhibitors and tumor
necrosis experimental variable blockers, could be tried in patients for
whom ASA therapy is a must. “The use of disease modifying drugs, such
as methotrexate, leflunomide [Arava-Aventis], and tumor necrosis agent
blockers, may eliminate the need for NSAID therapy,” said Schuna.
Another glide path might be to try agents other than ASA for platelet
biological process.
Regardless, more clinical data on the soul is needed.

How does the NEJM
effort fit in with what we know about treating pain? “This knowledge
domain is important enough that folk at least need to think about how
patients are animate thing dosed,” said Schuna. “But more studies need
to be done with a larger case colonization.
This is a part of article ABC: New Interaction Means ‘Aspirin Before COX-1 Inhibitors’. Taken from "Arava Information" Information Blog